IMMUNO AKTIENGESELLSCHAFT
Patent Owner
Stats
- 23 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 29, 2005 most recent publication
Details
- 23 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,842 Total Citation Count
- May 27, 1980 Earliest Filing
- 63 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6034222 Method for the separation of recombinant pro-factor IX from recombinant factor IXOct 04, 95Mar 07, 00[A61K, A23J]
5892005 High molecular and low molecular fractions of von willebrand factorDec 19, 96Apr 06, 99[C07K]
5872099 High molecular and low molecular fractions of von Willebrand FactorDec 19, 96Feb 16, 99[A61K]
5753489 Method for producing viruses and vaccines in serum-free cultureJun 07, 95May 19, 98[A61K, C12N]
5733885 Method of producing a virus-safe biological preparationJul 15, 96Mar 31, 98[A61K, C12N, C07K, A61L]
5639730 Method of producing a virus-safe biological preparationDec 14, 93Jun 17, 97[A61K, C12N, C07K, A61L]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6872550 Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigensExpiredAug 19, 94Mar 29, 05[A61K, C07H, C12N, C07K]
2002/0034,809 PROCESS FOR PRODUCING A PLASMA PROTEIN-CONTAINING MEDICAMENTAbandonedApr 02, 99Mar 21, 02[A61K, C12N]
6352856 Chimeric poxvirus comprising sequences of a retroviral vector componentExpiredJan 12, 99Mar 05, 02[C12N]
5863896 Evaluation of substances for altering and for increasing APC responseExpiredNov 09, 95Jan 26, 99[A61K, A01N, C12Q]
5864016 Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatmentExpiredJul 28, 94Jan 26, 99[A61K, C12N]
5833984 Composition and method for preventing and treating inflammation with Immunoglobulin AExpiredDec 23, 96Nov 10, 98[A61K, C07K]
5808000 Virus-safe monomeric human immunoglobulin A and methods for its productionExpiredJul 10, 95Sep 15, 98[C07K]
5804181 Pharmaceutical preparation for the prevention and treatment of blood coagulation disordersExpiredMay 26, 95Sep 08, 98[A61K]
5792623 Method for producing activated blood factors with a protease and a detergentExpiredJun 07, 95Aug 11, 98[A61K, C12P, C12N]
5770199 Method for virus inactivation in the presence of polyalkylene glycol as well as the pharmaceutical preparation obtained therewithExpiredJun 28, 96Jun 23, 98[A61K]
5770212 Recombinant poxviruses with foreign DNA in essential regionsExpiredFeb 21, 97Jun 23, 98[A61K]
5766882 recombinant poxviruses with foreign DNA in essential regionsExpiredMar 14, 96Jun 16, 98[C12P, C12N]
5643739 Assay for determining sensitivity to activated protein CExpiredMay 01, 95Jul 01, 97[C12Q, G01N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.